In a press release Thursday, UCB revealed a plan to establish a "new, state-of-the-art biologics manufacturing facility in the United States." The company hasn't settled on the exact location, but it says the site will create 300 high-skilled jobs once complete. Source: Fierce Pharma 12/6/2025